# Finerenone in Patients With IgA-nephropathy: Prospective Interventional Trial

> **NCT07056595** · NA · RECRUITING · sponsor: **Botkin Hospital** · enrollment: 30 (estimated)

## Conditions studied

- IgA Nephropathy (IgAN)

## Interventions

- **DRUG:** Finerenone

## Key facts

- **NCT ID:** NCT07056595
- **Lead sponsor:** Botkin Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-21
- **Primary completion:** 2026-05-21
- **Final completion:** 2026-05-21
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07056595

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07056595, "Finerenone in Patients With IgA-nephropathy: Prospective Interventional Trial". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07056595. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*